Gopalakrishnan, Vancheswaran
AstraZeneca,
United Kingdom
2025 Rank: 62377
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1890 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62377 | 69871 |
| Total Cites | 2896 | 2989 |
| H-index | 20 | 20 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 666 | 680 |
| Number of Single+First+Last Authored Papers | 7 | 7 |
| Total Cites to Single+First+Last Authored Papers | 666 | 680 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2229 | 2283 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.31 |
| Self-Citation Percentage |
3.11%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2246 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68857 | 74375 |
| Total Cites | 2807 | 2963 |
| H-index | 18 | 19 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 679 | 706 |
| Number of Single+First+Last Authored Papers | 7 | 7 |
| Total Cites to Single+First+Last Authored Papers | 679 | 706 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2093 | 2176 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.36 |
| Self-Citation Percentage |
5.26%
|
|
Gopalakrishnan, Vancheswaran
AstraZeneca,
United States
2023 Rank: 64852
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2344 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64852 | 69840 |
| Total Cites | 2732 | 2888 |
| H-index | 18 | 18 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 727 | 763 |
| Number of Single+First+Last Authored Papers | 7 | 7 |
| Total Cites to Single+First+Last Authored Papers | 727 | 763 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2061 | 2132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.35 |
| Self-Citation Percentage |
5.40%
|
|
Gopalakrishnan, Vancheswaran
University of Texas MD Anderson Cancer Center,
United States
2022 Rank: 61611
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2345 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61611 | 67132 |
| Total Cites | 2506 | 2693 |
| H-index | 17 | 18 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 700 | 742 |
| Number of Single+First+Last Authored Papers | 7 | 7 |
| Total Cites to Single+First+Last Authored Papers | 700 | 742 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1914 | 2010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.34 |
| Self-Citation Percentage |
6.94%
|
|
Gopalakrishnan, Vancheswaran
AstraZeneca,
United States
2021 Rank: 82673
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2977 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82673 | 86955 |
| Total Cites | 3101 | 3351 |
| H-index | 17 | 18 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 988 | 1039 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 988 | 1039 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2433 | 2562 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.31 |
| Self-Citation Percentage |
7.46%
|
|
Gopalakrishnan, Vancheswaran
University of Texas MD Anderson Cancer Center,
United States
2020 Rank: 103481
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3588 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103481 | 117807 |
| Total Cites | 1442 | 1533 |
| H-index | 13 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 590 | 608 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 590 | 608 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1167 | 1220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
5.94%
|
|